Abstract
Purpose and objective
Bone resection regarding adequate surgical margins is the treatment of choice for malignant bone tumors. In the case of metastasis-related complications, so-called skeletal-related events, it is highly important to achieve pain relief and a stable joint situation to re-mobilize the patients immediately following surgery. To bridge the often large osseous defect zones after tumor resection, both cemented and uncemented modular endoprosthetic systems are widely used. Patients undergoing tumor-related endoprosthetic orthopedic surgery are facing high risk for develo** a periprosthetic joint infection (PJI). The immunocompromised condition due to anti-neoplastic treatment and long operation time with large exposure of tissue contributes to a high risk of infection.
Methods
The authors present a case series of 100 patients (31% primary bone tumor and 69% metastasis-related surgery) undergoing tumor-related lower limb salvage surgery with special regard to periprosthetic joint infection and the management of this “difficult to treat” situation. Furthermore, a review of the current literature regarding infection following bone tumor resection and endoprosthetic reconstruction is performed and discussed.
Results
The median follow-up was 24 months (range 12–108 months). Ten patients (10%) suffered from a periprosthetic joint infection. We recorded six acute infections (type I) <4 weeks after surgery, one infection >4 weeks after surgery (type II), and three late infections (type III). According to the definition of Laffer et al., three of our patients (30%) are probably free of infection, one patient died of PJI-associated sepsis, and five patients were free of infection, but without restoration of the affected joint.
Conclusion
In conclusion, our own results show that perimegaprosthetic joint infection among silver-coated implants, in patients undergoing tumor-related surgery of the lower limb, is lower compared to non-silver-coated implants. Due to heterogeneity of patients and potential treatment options, the treatment regime should be tailored for the patients’ individual situation.
Similar content being viewed by others
References
Heisel C, Kinkel S, Bernd L, Ewerbeck V (2006) Megaprostheses for the treatment of malignant bone tumours of the lower limbs. Int Orthop 30(6):452–457. doi:10.1007/s00264-006-0207-7
Graci C, Maccauro G, Muratori F, Spinelli MS, Rosa MA, Fabbriciani C (2010) Infection following bone tumor resection and reconstruction with tumoral prostheses: a literature review. Int J Immunopathol Pharmacol 23(4):1005–1013
Ercolano LB, Christensen T, McGough R, Weiss K (2013) Treatment solutions are unclear for perimegaprosthetic infections. Clin Orthop Relat Res 471(10):3204–3213. doi:10.1007/s11999-013-2852-7
Cho WH, Song WS, Jeon DG, Kong CB, Kim JI, Lee SY (2012) Cause of infection in proximal tibial endoprosthetic reconstructions. Arch Orthop Trauma Surg 132(2):163–169. doi:10.1007/s00402-011-1405-3
Eckardt JJ, Eilber FR, Rosen G, Mirra JM, Dorey FJ, Ward WG, Kabo JM (1991) Endoprosthetic replacement for stage IIB osteosarcoma. Clin Orthop Relat Res 270:202–213
Flint MN, Griffin AM, Bell RS, Wunder JS, Ferguson PC (2007) Two-stage revision of infected uncemented lower extremity tumor endoprostheses. J Arthroplast 22(6):859–865. doi:10.1016/j.arth.2006.11.003
Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–171. doi:10.1097/01.blo.0000223978.36831.39
Gosheger G, Goetze C, Hardes J, Joosten U, Winkelmann W, von Eiff C (2008) The influence of the alloy of megaprostheses on infection rate. J Arthroplast 23(6):916–920. doi:10.1016/j.arth.2007.06.015
Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, Hornicek FJ, Temple HT, Ruggieri P, Letson GD (2011) Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Jt Surg Am 93(5):418–429. doi:10.2106/JBJS.J.00834
Holzer G, Windhager R, Kotz R (1997) One-stage revision surgery for infected megaprostheses. J Bone J Surg Br 79(1):31–35
Jeys LM, Kulkarni A, Grimer RJ, Carter SR, Tillman RM, Abudu A (2008) Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Jt Surg Am 90(6):1265–1271. doi:10.2106/JBJS.F.01324
Morii T, Yabe H, Morioka H, Beppu Y, Chuman H, Kawai A, Takeda K, Kikuta K, Hosaka S, Yazawa Y, Takeuchi K, Anazawa U, Mochizuki K, Satomi K (2010) Postoperative deep infection in tumor endoprosthesis reconstruction around the knee. J Orthop Sci Off J Jpn Orthop Assoc 15(3):331–339. doi:10.1007/s00776-010-1467-z
Roberts P, Chan D, Grimer RJ, Sneath RS, Scales JT (1991) Prosthetic replacement of the distal femur for primary bone tumours. J Bone Jt Surg Br 73(5):762–769
Wirganowicz PZ, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM (1999) Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res 358:64–74
Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M (1994) Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Jt Surg Br 76(2):178–186
Renard AJ, Veth RP, Schreuder HW, van Loon CJ, Koops HS, van Horn JR (2000) Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol 73(4):198–205
McPherson EJ, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M (2002) Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res 403:8–15
Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH (2004) Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop Relat Res 427:52–56
Sokolovski VA, Voloshin VP, Aliev MD, Zubikov VS, Saravanan SA, Martynenko DV, Nisichenko DV, Strelnikov KN (2006) Total hip replacement for proximal femoral tumours: our midterm results. Int Orthop 30(5):399–402. doi:10.1007/s00264-006-0124-9
Farid Y, Lin PP, Lewis VO, Yasko AW (2006) Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res 442:223–229
Myers GJ, Abudu AT, Carter SR, Tillman RM, Grimer RJ (2007) Endoprosthetic replacement of the distal femur for bone tumours: long-term results. J Bone Jt Surg Br 89(4):521–526. doi:10.1302/0301-620X.89B4.18631
Bickels J, Wittig JC, Kollender Y, Henshaw RM, Kellar-Graney KL, Meller I, Malawer MM (2002) Distal femur resection with endoprosthetic reconstruction: a long-term followup study. Clin Orthop Relat Res 400:225–235
Guo Z, Li J, Pei GX, Li XD, Wang Z (2010) Pelvic reconstruction with a combined hemipelvic prostheses after resection of primary malignant tumor. Surg Oncol 19(2):95–105. doi:10.1016/j.suronc.2009.04.003
Aljassir F, Beadel GP, Turcotte RE, Griffin AM, Bell RS, Wunder JS, Isler MH (2005) Outcome after pelvic sarcoma resection reconstructed with saddle prosthesis. Clin Orthop Relat Res 438:36–41
Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, Malawer MM (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65(6):1123–1132
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR, Infectious Diseases Society of A (2013) Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 56(1):1–10. doi:10.1093/cid/cis966
Patel R, Osmon DR, Hanssen AD (2005) The diagnosis of prosthetic joint infection: current techniques and emerging technologies. Clin Orthop Relat Res 437:55–58
Laffer RR, Graber P, Ochsner PE, Zimmerli W (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect Off Publ Euro Soc Clin Microbiol Infect Dis 12(5):433–439. doi:10.1111/j.1469-0691.2006.01378.x
Wimmer MD, Randau TM, Petersdorf S, Pagenstert GI, Weisskopf M, Wirtz DC, Gravius S (2013) Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop 37(11):2271–2278. doi:10.1007/s00264-013-1995-1
Donati D, Biscaglia R (1998) The use of antibiotic-impregnated cement in infected reconstructions after resection for bone tumours. J Bone Jt Surg Br 80(6):1045–1050
Donati D, D’Arenzo R, Ercolani C, Boriani S (1995) Infection in limb salvage surgery for bone tumors. Euro J Orthop Surg Traumatol Orthop Traumatol 5(1):71–74. doi:10.1007/BF02716222
Grimer RJ, Belthur M, Chandrasekar C, Carter SR, Tillman RM (2002) Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop Relat Res 395:193–203
Grimer RJ, Carter SR, Tillman RM, Sneath RS, Walker PS, Unwin PS, Shewell PC (1999) Endoprosthetic replacement of the proximal tibia. J Bone Jt Surg Br 81(3):488–494
Hardes J, Gebert C, Schwappach A, Ahrens H, Streitburger A, Winkelmann W, Gosheger G (2006) Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 126(5):289–296. doi:10.1007/s00402-005-0009-1
Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, Hauschild G, Ahrens H (2010) Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 101(5):389–395. doi:10.1002/jso.21498
Kuhne CA, Taeger G, Nast-Kolb D, Ruchholtz S (2003) Knee arthrodesis after infected tumor mega prosthesis of the knee using an intramedullary nail for callus distraction. Langenbeck’s Arch Surg Dtsch Ges Fur Chir 388(1):56–59. doi:10.1007/s00423-003-0360-z
Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, Kotz R (2001) Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res 388:167–177
Jeys L, Grimer R (2009) The long-term risks of infection and amputation with limb salvage surgery using endoprostheses. Recent Results Cancer Res Fortschr Der Krebsforsch Progres Dans Les Rech Sur Le Cancer 179:75–84
Piccioli A, Donati F, Giacomo GD, Ziranu A, Careri S, Spinelli MS, Giannini S, Giannicola G, Perisano C, Maccauro G (2016) Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs. Injury. doi:10.1016/j.injury.2016.07.054
Donati F, Di Giacomo G, Ziranu A, Spinelli S, Perisano C, Rosa MA, Maccauro G (2015) Silver coated prosthesis in oncological limb salvage surgery reduce the infection rate. J Biol Regul Homeost Agents 29(4 Suppl):149–155
Ogose A, Hotta T, Kawashima H, Kawaji Y, Endo N (2005) Ischial weight-bearing brace after the infection of megaprosthesis a salvage method for resection arthroplasty. J Arthrop 20(7):954–956. doi:10.1016/j.arth.2005.07.004
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Schmolders, J., Koob, S., Schepers, P. et al. Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature. Arch Orthop Trauma Surg 137, 149–153 (2017). https://doi.org/10.1007/s00402-016-2584-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-016-2584-8